Bulletin
Investor Alert

London Markets Close in:

Omeros Corp.

NAS: OMER

GO
/marketstate/country/us

Market open

/zigman2/quotes/210447752/composite

$

15.92

Change

+0.08 +0.51%

Volume

Volume 77,431

Sep 23, 2021, 11:05 a.m.

Real time quotes

/zigman2/quotes/210447752/composite

Previous close

$ 15.84

$ 15.92

Change

+0.08 +0.51%

Day low

Day high

$15.73

$16.06

Open
Open: 15.97

52 week low

52 week high

$9.25

$23.85

Open

Market cap

$989.93M

Average volume

371,766

P/E ratio

N/A

Rev. per Employee

$266,473

EPS

-2.29

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/omer

MarketWatch News on OMER

  1. Omeros started at buy with $25 stock price target at UBS

    9:37 a.m. Feb. 1, 2021

    - Tomi Kilgore

  2. Omeros stock price target cut to $20 from $25 at Maxim Group

    7:26 a.m. Aug. 14, 2020

    - Tomi Kilgore

  3. Omeros stock gains on transplant drug data

    11:38 a.m. Dec. 4, 2019

    - Jaimy Lee

  4. Omeros stock price target cut to $25 from $32 at Maxim Group

    8:59 a.m. Nov. 13, 2019

    - Tomi Kilgore

  5. How to spot risky biotech companies and six to avoid now

    6:14 a.m. Jan. 17, 2019

    - Michael Brush

  6. Omeros stock drops 45% after kidney disease trial results

    3:15 p.m. Oct. 1, 2018

    - Emma Court

  7. Omeros stock price target cut to $19 from $47 at Wedbush

    7:00 a.m. March 23, 2018

    - Tomi Kilgore

  8. Omeros downgraded to neutral from outperform at Wedbush

    7:00 a.m. March 23, 2018

    - Tomi Kilgore

  9. Dow closes more than 700 points lower as trade fears spark plunge

    4:45 p.m. March 22, 2018

    - Ryan Vlastelica

  10. Omeros shares surge 50% on spending bill that benefits its drug

    8:41 a.m. March 22, 2018

    - Emma Court

  11. Omeros shares surge 17% after Q3 revenue beat

    9:24 a.m. Nov. 10, 2017

    - Emma Court

  12. Omeros shares surge 7% after settlement with Endo's Par Pharma

    11:13 a.m. Oct. 5, 2017

    - Emma Court

  13. Endo shares drop 3.7% after news of settlement with Omeros

    11:14 a.m. Oct. 5, 2017

    - Emma Court

  14. Charting the Market

    12:27 a.m. June 17, 2017

    - Barron's Online

  15. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/omer

Other News on OMER

  1. Omeros: The Prize Is Nigh (Again)

    11:08 p.m. Sept. 13, 2021

    - Seeking Alpha

  2. Omeros (OMER) Reports Q2 Loss, Tops Revenue Estimates

    5:35 p.m. Aug. 9, 2021

    - Zacks.com

  3. Omeros: PDUFA Delay Presents An Opportunity

    10:45 a.m. July 3, 2021

    - Seeking Alpha

  4. Omeros' (OMER) BLA for Narsoplimab Gets Extended Review

    9:55 a.m. May 21, 2021

    - Zacks.com

  5. PRPO, ADES, RIDE and REGI among midday movers

    12:40 p.m. May 20, 2021

    - Seeking Alpha

  6. FDA extends review period for Omeros' narsoplimab BLA

    8:59 a.m. May 20, 2021

    - Seeking Alpha

  7. Omeros (OMER) Reports Q1 Loss, Misses Revenue Estimates

    5:55 p.m. May 10, 2021

    - Zacks.com

  8. 10-Q: OMEROS CORP

    4:20 p.m. May 10, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  9. Loading more headlines...
/news/pressrelease/company/us/omer

Press Releases on OMER

  1. Drugs Used for Huntington's Disease Treatment Market 2027

    3:38 p.m. Aug. 12, 2021

    - AmericaNewsHour

  2. Omeros Corporation Reports Second Quarter 2021 Financial Results

    4:02 p.m. Aug. 9, 2021

    - BusinessWire - BZX

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.